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Structural basis of Cullin 2 RING E3 ligase
regulation by the COP9 signalosome
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Cullin-Ring E3 Ligases (CRLs) regulate a multitude of cellular pathways through speciﬁc
substrate receptors. The COP9 signalosome (CSN) deactivates CRLs by removing NEDD8
from activated Cullins. Here we present structures of the neddylated and deneddylated CSN-
CRL2 complexes by combining single-particle cryo-electron microscopy (cryo-EM) with
chemical cross-linking mass spectrometry (XL-MS). These structures suggest a conserved
mechanism of CSN activation, consisting of conformational clamping of the CRL2 substrate
by CSN2/CSN4, release of the catalytic CSN5/CSN6 heterodimer and ﬁnally activation of the
CSN5 deneddylation machinery. Using hydrogen-deuterium exchange (HDX)-MS we show
that CRL2 activates CSN5/CSN6 in a neddylation-independent manner. The presence of
NEDD8 is required to activate the CSN5 active site. Overall, by synergising cryo-EM with MS,
we identify sensory regions of the CSN that mediate its stepwise activation and provide a
framework for understanding the regulatory mechanism of other Cullin family members.
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Cullin-RING Ligases (CRLs) are modular, multi-subunitcomplexes that constitute a major class of ubiquitin E3ligases1,2. CRLs coordinate the ubiquitination of substrates
as either a signal for degradation via the 26S proteasome, or to
alter the function of the target protein2,3. The CRL2 E3 ligase
consists of a Cullin 2 (CUL2) scaffold in association with a cat-
alytic RING-box protein (RBX1), with the substrate adaptors
Elongin B (ELOB) and C (ELOC) at its N-terminal4. When
associated with the von Hippel–Lindau (VHL) tumour sup-
pressor substrate receptor, the CRL2 complex is the primary
regulator of the Hypoxia Inducible Factor 1-α (HIF-1α) tran-
scription factor5,6. Mutations in the interface between VHL,
ELOB and ELOC can deactivate CRL2 leading to an accumula-
tion of HIF-1α, which can in turn drive tumorigenesis through
the over-activation of oncogenes7. Moreover, CRL2 has recently
been identiﬁed as a potential target for small molecular inhibitors
and PROTACs—a new class of cancer drugs that promote
degradation of tumorigenic gene products8–10. These fascinating
systems have been described in detail by a number of excellent
reviews1–3.
Activation of CRL2, in common with other members of the
CRL family, involves a cascade of E1, E2 and E3 enzymes, which
conjugate the ubiquitin-like protein NEDD8 (N8) to residue
K689 on the CUL2 scaffold11. In its activated state, CRL2~N8
(the ~ stylisation denotes a covalent interaction) recruits the
ubiquitin-conjugated E2 enzyme via the RING domain of
RBX112. Ubiquitination now takes place, covalently adding ubi-
quitin to the substrate molecule docked at the CRL2 N-terminal.
The activity of CRL2 is negatively regulated by the 331 kDa
Constitutive Photomorphogenesis 9 Signalosome (CSN) complex,
frequently referred to as the COP9 signalosome complex13–15.
The CSN was originally identiﬁed as consisting of eight subunits
(designated as CSN1–8 by decreasing molecular weights of 57–22
kDa), and is organised in a splayed hand architecture, which has
high sequence and structural homology to the proteasome
lid13,14,16–18. CSN1, 2, 3, 4, 7 and 8 are structurally homologous
to each other and together contribute to the ﬁngers of the splayed
hand which arise from extended N-terminal α-helical repeats16,18.
Each CSN1-8 subunit includes an extended C-terminal helix
which associates together forming a C-terminal helical bundle.
CSN5 and 6 are also closely related structurally and form a
globular heterodimer located on the palm of the hand. CSN5 is
responsible for the deneddylase activity of the CSN. A ninth
subunit, CSNAP, has recently been identiﬁed, and is thought to
play a role in stabilising the CSN complex18.
Electron microscopy (EM) based structural analysis has pro-
vided important insights into the mechanism of CRL1 regulation
by CSN16,19. CRL4A and CRL3 have also been observed to form
such complexes20. However, despite intense interest, structural
information of the CSN bound to CRLs remains limited to
CRL112,16,19, CRL4A20, and a low-resolution map of a dimeric
CSN–CRL3~N820 complex. In particular, the analysis of the
CSN–CRL4A~N8 complex20 identiﬁed at least three major steps
by which CRL~N8 is deneddylated by the CSN. In the ﬁrst step,
the extended N-terminal helical modules of CSN2 and CSN4
conformationally clamp the C-terminal domain of the
CRL4A~N8 and RBX116,19,20. The second step involves the
release and consequent relocation of CSN5/CSN6 closer to
NEDD8, brought about by disruption of the CSN4/CSN6 inter-
face20. Disrupting the binding interface between CSN4/CSN6
through removal of the CSN6 insertion-2 loop (Ins-2), resulted in
enhanced deneddylase activity13, presumably due to more com-
plete release of CSN5/CSN6. In the ﬁnal step, the mobile CSN5
binds to NEDD8, leading to deneddylation via its JAB1/MPN/
MOV34 (JAMM) metalloprotease domain21. The JAMM motif
consists of H138, H140 and D151 zinc-coordinating residues, and
residue E104 of the CSN5 insertion-1 loop (Ins-1)13. In apo-CSN,
the Ins-1 loop occludes the CSN5 active site, auto-inhibiting the
deneddylase13,22. Deneddylation is also severely diminished by a
H138A point mutation in CSN513.
Surprisingly, the CSN can also form complexes with each of the
Cullin 1–5 family members even without NEDD823. Free CRLs
such as CRL1 have been reported to readily bind and inhibit the
CSN, albeit at relatively lower afﬁnity than the neddylated
CRL124. While the exact role of CSN–CRL complexes remains
unclear, it has been hypothesised that these complexes may
function to regulate the cellular level of ubiquitin ligase activity of
CRLs once they have been deneddylated, effectively sequestering
E3 ligases from the intracellular environment24.
Building on the existing knowledge of the CSN–CRL systems,
here we pose the question: are similar structural changes to be
found in other CSN–CRL complexes, and how does binding of
neddylated CRLs lead to activation of the CSN5 catalytic site? To
address this, we present structures of the CSN–CRL2~N8 com-
plex, together with the structure of the CSN–CRL2 deneddylation
product. We complement our cryo-EM analysis with chemical
cross-linking mass spectrometry (XL-MS) allowing us to clarify
the positions of particularly dynamic regions in the complexes.
We use hydrogen-deuterium exchange mass spectrometry (HDX-
MS) to interrogate the role of the CSN4/CSN6 interface in
communicating CRL binding to the CSN5 active site. Overall, our
structures of the CSN–CRL2~N8 and its deneddylation product,
the CSN–CRL2, reveal the intricate conformational changes of
CSN that lead to deneddylation of the CRL2.
Results
Cryo-EM structures of the CSN–CRL2~N8 complex. To study
the molecular interactions between neddylated CRL2 (CRL2~N8)
and the CSN, we performed single-particle cryo-EM to resolve a
structure of the assembled CSN–CRL2~N8 (referred to as the
holocomplex) (Supplementary Figs. 1 and 2). The H138A
mutation in the catalytic site of CSN5 subunit makes it possible to
assemble CSN–CRL2~N8 complexes in which NEDD8 remains
covalently attached over the time scale of the experiment16,19. To
justify the use of the H138A point mutation, we performed a
band-shift assay comparing the deneddylation activity of the
CSNWT and CSN5H138A mutant enzymes (Supplementary Fig. 3).
As expected, CSNWT rapidly cleaves NEDD8 from CRL2~N8
within seconds of incubation, while little to no deneddylation
activity is seen from the CSN5H138A complex (Supplementary
Fig. 3). This mutant form of CSN was used throughout the work
described below, unless otherwise speciﬁed.
Using 3D classiﬁcation, we were able to generate maps of three
different structures: (a) a holocomplex map at 8.2 Å, (b) a map of
the complex with little or no density for VHL at 8.0 Å, and (c) a
map of the complex with little or no density for CSN5/CSN6/
VHL at 6.5 Å (Supplementary Figs. 2, 4, and 5). The two partial
complexes likely arise from compositional heterogeneity in the
original samples from which the structural analysis has succeeded
in isolating subpopulations. To verify the existence of subcom-
plexes, we subjected the CSN–CRL2~N8 to native MS (Supple-
mentary Fig. 6, Supplementary Data 1). In line with
subpopulation observations from our cryo-EM, we identiﬁed
subcomplexes of the CSN–CRL2~N8 missing the CSN5, VHL,
ELOB or ELOC subunits. These observations support the notion
that similar levels of heterogeneity observed in the cryo-EM
analysis of other CSN–CRL complexes, CSN–CRL1~N8 and
CSN–CRL4A~N819,20 is also likely to arise from variable subunit
composition and may be ubiquitous to all CSN–CRL complexes.
Next, we ﬁtted into each map, the highest resolution crystal-
lographic structure of the CSN (PDB 4D10)13 and a homology
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model of the CRL2 (including the VHL-ELOB-ELOC) using
molecular dynamics ﬂexible ﬁtting (MDFF)25 (Table 1; “Meth-
ods” section). In the model of the holocomplex (8.2 Å), the main
interactions occur between the C-terminal end of CUL2 and the
extended N-terminal helical repeats of CSN2 and CSN4 (Fig. 1a,
b). Compared with their conformation in the highest resolution
apo-CSN crystal structure13 (PDB 4D10), CSN2 and CSN4 are
moved by 30 and 51 Å, respectively, towards CUL2 (Fig. 1e,
Supplementary Movie 1). We additionally reviewed the con-
formations of CSN2 and CSN4 in all nine available intact
structures of the apo-CSN (PDBs 4D10, 4D18 and 4WSN;
Supplementary Fig. 7). We compared each of the apo-CSN
structures with our holocomplexes and with other ﬁtted models
of the CSN in complex with CRL1~N8 and CRL4A~N8.
Signiﬁcant structural variation in CSN2 and CSN4 is observed
within these apo-CSN structures, but in all cases, their
conformations were substantially different to any found in the
holocomplexes. In each of our CSN–CRL2 structures, the
clamping motion of CSN2 and CSN4 is a swinging rotation
about hinges located close to the CSN2 and CSN4 winged helix
domains. For CSN2 this is coupled with an additional rotation
about the axis of the superhelix formed from its N-terminal
helical repeats. In the case of CSN4 the movement is coupled to
the detachment of CSN4 from the Ins-2 loop of CSN6 by ~30 Å
and leads to an ~12 Å shift in CSN5 (Fig. 1c, f). Only minor
conformational changes were found in the CSN1, CSN3, CSN7B
or CSN8 subunits. In the CRL2~N8 moiety, a number of
relatively small rearrangements of CUL2, RBX1, ELOB, ELOC
and VHL subunits were observed compared to its crystal
structure26 (Supplementary Fig. 8a, b).
In our EM maps and the other published CSN–CRL
structures16,19,20, the exact position of NEDD8 and the CUL2
Winged-Helix B (WHB) domain were difﬁcult to determine. To
address this limitation, we carried out XL-MS experiments on the
CSN–CRL2~N8 complex using the bis(sulfosuccinimidyl)suberate
(BS3) cross-linker which targets lysine side chains (“Methods”
section). We identiﬁed a total of 24 inter- and 60 intra-protein
cross-links (Supplementary Data 2, Supplementary Fig. 9a, b). To
generate a model of the CSN–CRL2~N8, we performed cross-link
guided modelling which allows the placement of the WHB,
NEDD8 and VHL subunits using identiﬁed cross-links from XL-
MS (“Methods” section). We imposed a cross-link distance
threshold of 35 Å which takes into account the length of two
lysine side chains (15 Å), the BS3 cross-linker length (10 Å) and an
extra 10 Å to allow for domain-level ﬂexibility (“Methods” section).
Our model of the CSN–CRL2~N8 satisﬁes all cross-link distances
(Supplementary Fig. 9c). Three cross-links between CUL2-WHB
(CUL2K382-WHBK720, CUL2K382-WHBK677 and CUL2K433-
WHBK677) were used for the positioning of the WHB domain
(Supplementary Fig. 9d, red text). A further two cross-links
between CUL2 and NEDD8 (CUL2K382-N8K33 and CUL2K433-
N8K6) allowed the positioning of NEDD8 near CSN5 (Fig. 1d,
Supplementary Fig. 9d, green text). In this conformation, the
isopeptide bond of NEDD8 is juxtaposed to the CSN5 active site.
For the isopeptide bond of NEDD8 to reach the CSN5 active site,
the WHB domain must be extended from its crystallographic
conformation towards the CSN5 by 19Å (Supplementary Fig. 9e).
Structure of the deneddylated CSN–CRL2 complex. Having
determined the structure of the CSN–CRL2~N8 complex, we next
sought to detail any conformational differences in the deneddy-
lated CSN–CRL2. The afﬁnity of CSN for non-neddylated CRLs is
signiﬁcantly lower than for the neddylated forms, limiting the
yield of the desired product19. To stabilise the formation of a
complex between CSN and CRL2, we employed GraFix27
(“Methods”) prior to cryo-EM. Moreover, native MS conﬁrmed
Table 1 Cryo-EM data collection, reﬁnement and validation statistics
CSN–CRL2~N8
(holocomplex) (EMB-
4739) (PDB 6R7F)
CSN−CSN5/CSN6-
CRL2−VHL~N8 (EMB-
4744) (PDB 6R7N)
CSN–CRL2−VHL~N8 (CSN5/
CSN6 reﬁned) (EMB-4742)
(PDB 6R7I)
CSN–CRL2~N8 (VHL
reﬁned) (EMB-4736)
(PDB 6R6H)
CSN–CRL2
(EMB-4741)
(PDB 6R7H)
Data collection and processing
Magniﬁcation 47,170 47,170 47,170 47,170 47,755
Voltage (kV) 300 300 300 300 300
Electron
exposure
(e-/Å−2)
45 45 45 45 83
Defocus
range (μM)
1.8–3.0 1.8–3.0 1.8–3.0 1.8–3.0 1.8–3.0
Pixel size (Å) 1.060 1.060 1.060 1.060 1.047
Symmetry
imposed
C1 C1 C1 C1 C1
Initial number
of particles
316,921 316,921 316,921 316,921 308,936
Final number
of particles
20,055 22,471 24,552 24,049 17,191
Map
resolution (Å)
8.2 6.5 8.0 8.4 8.8
FSC threshold 0.143 0.143 0.143 0.143 0.143
Map
resolution
range (Å)
6.7–22.7 5.9–8.0 5.9–11.5 6.3–17.4 5.6–16.8
Reﬁnement
Subunits
missing
None CSN5/CSN6, VHL VHL None None
Initial
PDB used
4D10, 5N4W,
4WQO, 3DQV
4D10, 5N4W, 4WQO 4D10, 5N4W, 4WQO 4D10, 5N4W, 4WQO 4D10,
5N4W, 4WQO
Number of
residues
3727 2974 3578 3716 3251
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the formation of CSN–CRL2 complex (Supplementary Fig. 10,
Supplementary Data 1). We next resolved a cryo-EM map of the
CSN–CRL2 to 8.8 Å resolution (Supplementary Figs. 11, 12).
Although the resolution of the CSN–CRL2 map is similar to that
for CSN–CRL2~N8 holocomplex, we only observed partial den-
sity for VHL and CSN4. Next using the same procedure as for the
neddylated CSN–CRL2~N8 complex, we ﬁtted CSN and
CRL2 subunits into the density map of the CSN–CRL2 complex
(“Methods” section). We then utilised cross-link guided model-
ling to establish the position of the WHB which lacked clear
density, similar to the neddylated holocomplex (Supplementary
Fig. 13; Supplementary Data 3; “Methods” section).
To determine whether the lack of density for the CSN4 may be
due to ﬂexibility of the CSN4 N-terminal domain, we carried out
XL-MS for the apo-CSN complex (Supplementary Fig. 14;
Supplementary Data 4). A total of 18 cross-links were identiﬁed
involving CSN4: 12 of which were intra-CSN4 cross-links, 4
between CSN2-CSN4 and 2 between CSN6–CSN4. We measured
the distances of these cross-links on the structure of the apo-CSN
(PDB 4D10) and on our cryo-EM ﬁtted model of the CSN–CRL2
(which represented the CSN4 in a lowered conformation;
Supplementary Fig. 14). Applying a 35 Å distance threshold,
we identiﬁed cross-links which were exclusively satisﬁed in each
of the two conformations of CSN4 (Supplementary Fig. 14,
“Methods”). The presence of exclusively satisﬁed cross-links
indicate that both conformations have been sampled experi-
mentally and suggest that the apo CSN4 can wave between the
two conformations represented by the crystal structure and
CSN4
(apo)
CSN6
(apo)
CSN6
(holo)
CSN5
(apo)
CSN5
(holo)
6.4 Å
12.0 Å
32.6 Å
a
b c d
f
CSN4
CUL2
CSN2
CSN2
CSN1
ELOB
ELOC
VHL
CSN3
CSN5
CSN5 Active site
Isopeptide
WHB
CUL2
CUL2
RBX1
N8
N8
CSN6
CSN8
CSN7
CSN6
Ins-2
CSN4
180°
~30 Å
e
CSN-CRL2~N8
4WSN
4D10
4WSN
4WSN
4D18
CSN4
CSN2
51.0 Å
29.9 Å
Fig. 1 Structures and interactions of the CSN–CRL2~N8 complex. a The molecular model of CSN–CRL2~N8 ﬁtted into cryo-EM density (8.2 Å resolution)
from front and back views. b Conformational clamping of CRL2~N8 by CSN2 and CSN4. Cross-links shown are between CSN4-RBX1 (CSN4K200-RBX1K105,
purple-green spheres), and four between CSN2–CUL2 (CSN2K157-CUL2K489, CSN2K263–CUL2K462, CSN2K225–CUL2K462, CSN2K64–CUL2K404, beige-blue
spheres). c View showing ~30 Å separation of CSN6 Ins-2 loop from CSN4 following CRL2~N8 binding. d Modelled position of WHB~N8 using cross-links
of the CSN–CRL2~N8. Large scale conformational changes (e) between CSN2 and CSN4 in all apo-CSN crystal structures (PDB 4WSN, 4D10 and 4D18)
and CSN–CRL2~N8 (f) CSN5/CSN6 (PDB 4D10) upon binding of CRL2~N8 (holo). Subunits of the CSN–CRL2~N8 were compared with the apo-CSN crystal
structure (PDB 4D10) following structural alignment. The structure of the CRL2~N8 has been hidden for clarity
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CRL2-bound structures, even in the absence of the
CRL2 substrate.
To evaluate any local changes across the CSN–CRL2~N8 in the
absence of NEDD8, we aligned the cryo-EM models of
neddylated and deneddylated holocomplexes using the C-
terminal helical bundle as a reference point (Supplementary
Fig. 15a, b). We systematically compared the conformations of
each subunit (Supplementary Fig. 15c–j, Supplementary Movie 1).
Compared with its structure in the CSN–CRL2~N8, the N-
terminal helices of CSN2 are shifted by ~21 Å towards the CUL2
C-terminal domain (Fig. 2b). This change in CSN2 in the absence
of NEDD8, leads to a structural difference in CUL2 which rotates
upwards towards the rest of the CSN by 20 Å (Fig. 2c). The
position adopted by CUL2 in the deneddylated holocomplex,
places ELOB closer to CSN1, forming a CSN1–ELOB interface
(Fig. 2d). An interface between CSN1–ELOB can also be seen in
the partial structures of CSN–CRL2~N8 missing VHL and CSN5/
CSN6 (Supplementary Fig. 2, Supplementary Fig. 16). The
dissociation of VHL and CSN5/CSN6 causes the N-terminus of
CUL2 to shift downwards, away from the CSN (Supplementary
Fig. 16). The plasticity of the CSN results in changes in the C-
terminus of CUL2, which is clamped between CSN2 and CSN4, in
order to accommodate this shift. The formation of the
CSN1–ELOB interface appears to arise as result of this movement
in both the deneddylated structure and the incomplete
CSN–CRL2~N8 structures. Interactions between substrate adap-
tor complexes and CSN1 have similarly been reported for the
CSN–CRL1~N816 and CSN–CRL4A~N820. RBX1 remains
clamped between CSN2 and CSN4 (Fig. 2e).
The most striking conformational differences were observed in
CSN6 (Fig. 2f, Supplementary Movie 1). In the absence of NEDD8,
CSN6 is dramatically shifted away from its position in the
neddylated holocomplex by ~40 Å (Fig. 2f). This previously
unknown conformation of CSN6 differs from the conformation
captured in our neddylated holocomplex, the CSN–CRL1~N819 and
CSN–CRL4A~N820 structures (Supplementary Figs. 17 and 18). We
compared the conformation of CSN6 seen in the structures of apo-
CSN (PDB 4D10), CSN–CRL1~N8 (EMD-3401), CSN–CRL4A~N8
(EMD-3315), CSN–CRL4ADDB2~N8 (EMD-3316) and our neddy-
lated and non-neddylated CSN–CRL2 complexes through systema-
tic structural alignments and measuring their pairwise root mean
squared deviation (RMSD) (Supplementary Figs. 17 and 18). The
conformation of CSN6 in the non-neddylated CSN–CRL2 complex
shows consistently high RMSD (16–25 Å) when compared with
CSN6 in any of the other complexes indicating a high degree of
conformational difference. CSN6 in the CSN–CRL2 structure has its
Ins-2 loop dramatically shifted away from its apo-CSN conforma-
tion, pointing upwards to CSN7B (Supplementary Fig. 17, Supple-
mentary Movie 1). We anticipate that this conformation of CSN6 in
our model of the non-neddylated CSN–CRL2 is attributed to the
lack of NEDD8. Similar to the neddylated holocomplex, no
signiﬁcant changes were identiﬁed in CSN3, CSN7B and
CSN8 subunits in the CSN–CRL2. Overall, comparison between
the CSN–CRL2~N8 and CSN–CRL2 structure reveal signiﬁcant
conformational rearrangements in CSN5/CSN6 and the N-terminal
domain of CSN2.
HDX-MS reveals a stepwise mechanism of CSN activation.
Having determined the structures of the neddylated and dened-
dylated CSN–CRL2 complexes, we set off to characterise the local
dynamics using HDX-MS. HDX-MS provides peptide-level
information on the dynamics of proteins through monitoring
the exchange events of amide hydrogens for bulk deuterium in
the surrounding solution environment26,28–33. Here, we per-
formed a set of two differential HDX-MS experiments to
determine the effect of: (a) CRL2~N8 binding to CSN, denoted as
Δ(CSN–CRL2~N8 - CSN), and (b) CRL2 binding to CSN,
denoted as Δ(CSNWT–CRL2 - CSNWT) (Fig. 3a, Supplementary
Figs. 19 and 20). Regions that exhibit signiﬁcant HDX differences
brought about by the addition of the ligand (i.e. CRL2 and
CRL2~N8) are labelled as stabilising (negative ΔHDX; coloured
blue) or destabilising (positive ΔHDX; coloured red).
In both Δ(CSN–CRL2~N8 - CSN) and Δ(CSNWT–CRL2 -
CSNWT) experiments, extensive regions in the N-terminal helices
of CSN2, CSN4 and the globular domain of RBX1 exhibited
stabilisation upon the incubation of CSN with its CRL2~N8 and
CRL2 substrates (Fig. 3b; Supplementary Fig. 21a, b). These
observations are in line with the conformational clamping by
CSN2/CSN4 onto the C-terminal of CRL2 as seen in the cryo-EM
structures of neddylated and deneddylated complexes. Within
CSN2 of both experiments, we observed signiﬁcantly destabilised
regions around helical modules 6–9. These observations have
likely identiﬁed the hinge points which permit the bending of
CSN2 to clamp onto the CUL2 C-terminus (Fig. 3b; Supplemen-
tary Fig. 21a, b). Stabilised peptides belonging to CSN1 (143–156)
and ELOB (17–25) were identiﬁed in the Δ(CSNWT–CRL2 -
CSNWT) condition, indicating that an interface exists between
CSN1–ELOB (Supplementary Fig. 22). It is noted that since
the CSNWT–CRL2 sample used for HDX were not treated with
GraFix (as they were for cryo-EM), it is unlikely that the
CSN1–ELOB interface is caused by glutaraldehyde cross-linking.
In the neddylated Δ(CSN–CRL2~N8 - CSN) condition, ELOB
(17–25) was not found due to the lack of proteomic coverage.
However, CSN1 (143–156) is stabilised, suggesting that the
CSN1–ELOB interface is present in the neddylated holocomplex.
To assess the afﬁnity between CSN4 and CRL2, we performed
PLIMSTEX (protein–ligand interactions by mass spectrometry,
titration and HDX) experiments (“Methods”). In these experi-
ments, we performed HDX-MS of CSN or CSNWT in the
presence of increasing concentrations of CRL2 or CRL2~N8, to
derive dissociation constants (Kd) between CSN4 and CRL2/
CRL2~N8. PLIMSTEX differs from differential HDX-MS in
several ways. First, no differential comparison is performed from
PLIMSTEX. Second, PLIMSTEX experiments utilise a single
deuteration time for all samples. PLIMSTEX requires a
sufﬁciently long deuteration time to observe differences between
holo and apo states, but short enough to prevent over-deuteration
of interfaces as the complex naturally dissociates and reassociates.
Finally, PLIMSTEX is a titration experiment which observes
deuteration changes as a function of ligand concentration, while
differential HDX-MS utilises a 1:1 molar ratio of our CSN and
CRL2 substrates.
We tested the afﬁnity of CSN4 for CRL2 or CRL2~N8 in
CSN–CRL2~N8, CSN–CRL2 and CSNWT–CRL2 complexes. Our
PLIMSTEX experiments identiﬁed three regions of CSN4 which
exhibit a dramatic decrease in deuterium uptake when exposed to
the CRL2 substrate. These regions correspond to CSN4 α-helices
which are in contact with CRL2~N8 in our cryo-EM ﬁtted model
of the CSN–CRL2~N8 (Supplementary Fig. 23). The Kd
measurements for the different regions of CSN4 in CSNWT–CRL2
(11.3–34.5 nM), CSN–CRL2 (138.1–218.8 nM) and CSN–
CRL2~N8 (118.9–389.0 nM) are each in the low nanomolar
region, suggesting limited differences in local afﬁnity brought
about by changes such as the neddylation status of CRL2. These
Kd values for the CSN–CRL2 system all fall within a similar
overall range to the published global Kd to the
CSN–CRL1 system19 (1.6–310 nM; Supplementary Table 1),
indicating a crucial role for CSN4 in stabilising CSN–CRL2. In
addition, HDX-MS based Kd measurements also allowed us to
localise individual regions of CSN4 responsible for interacting
with CRL2 at the peptide level. (Supplementary Fig. 23).
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Remodelling of the CSN5 active site in the presence of NEDD8.
We next considered the release mechanism of the CSN5/
CSN6 subunits of both the neddylated and deneddylated holo-
complexes. In both Δ(CSN–CRL2~N8 - CSN) and Δ
(CSNWT–CRL2 - CSNWT) experiments, the Ins-2 loop of CSN6
was destabilised, correlating with the release of CSN6 from its
interface with CSN4 and in line with the allosteric activation
mechanism of CSN by CRL4A~N820 (Fig. 4a, b i). An interesting
difference between the neddylated and deneddylated complexes is
that the CSN6 α4 helix is destabilised only in the absence of
NEDD8 (Fig. 4b i). Similarly, the CSN5 α7 helix is also destabi-
lised in both neddylated and deneddylated conditions (Fig. 4a, b
ii). The CSN6 α4 and CSN5 α7 helices are topologically knotted
in the CSN5/CSN6 heterodimer and tether the globular domains
of CSN5/CSN6 to the C-terminal helical bundle13. These obser-
vations suggest that structural changes are required in the helical
knot to bring about release of the CSN5/CSN6 globular domains
from their apo conformation.
Another ﬁnding is that we identiﬁed destabilisation in the Ins-2
loop of CSN5 (Fig. 4a, b ii). The Ins-2 loop of CSN5 has a lesser
understood role in CSN activation. In isolated CSN5, the Ins-2
loop is highly disordered22 (Supplementary Fig. 24a), while it
folds into a helical-loop structure when incorporated into the
CSN13 (Supplementary Fig. 24b). Accompanying the changes in
the CSN5 Ins-2 loop, in both comparative HDX-MS experiments,
we detected destabilisation of the α5 helix area which surrounds
the CSN5 active site (Fig. 4a, b ii). The changes in both the CSN5
Ins-2 and α5 helix indicate a major conformational remodelling
in the area adjacent to the CSN5 active site, which can be
triggered through the binding of both CRL2 or CRL2~N8 to the
CSN in a NEDD8-independent manner. It is only in the presence
of NEDD8, that the CSN5 active site is further destabilised
suggesting that in a ﬁnal activation step, NEDD8 induces
conformational changes in the active site itself (Fig. 4a–d). To
eliminate the possibility that the observed changes in the CSN5
active site are due to the H138A point mutation, we compared the
deuterium uptake proﬁles of CSN5 from apo-CSNWT and
CSN5H138A constructs (Supplementary Fig. 25). Calculating the
deuterium uptake differences between peptides of the CSN5WT
and CSN5H138A and visualising this through a Woods plot,
identiﬁed no signiﬁcant uptake differences (Supplementary
Fig. 25). With this considered, the deprotection observed in the
CSN5 active site of the CSN–CRL2~N8 complex can be seen to
result from the binding of CRL2~N8 and not the H138A
mutation of the CSN5 active site.
Discussion
Here we have combined EM and MS analyses to provide insights
into the mediation of CRL2 by the CSN. We have described the
molecular structures of CSN–CRL2~N8 and its deneddylated
CSN–CRL2 counterpart. Furthermore, we combined cryo-EM
maps with comparative HDX-MS to expand on the stepwise
activation mechanism of the CSN, involving a conformational
network of both NEDD8-independent and dependent stages. We
suggest that the steps which lead to deneddylation are mostly
NEDD8-independent, except for the remodelling of the CSN5
active site which requires NEDD8 to encounter the CSN5
active site.
Our map of the deneddylated CSN–CRL2 holocomplex
represents a complex in which the CSN is still associated with its
CRL2 reaction product. Resolving this structure has provided
several important details into how activation of the CSN is
achieved. Our comparison of the neddylated and deneddylated
holocomplex structures indicated that the CSN2 contacts the
CRL2 C-terminal domain in a slightly different conformation to
when the CRL2 is modiﬁed with NEDD8. Between both neddy-
lated and deneddylated conformations, we suggest that the
clamping by CSN2 involves destabilisation of the CSN2 helical
modules 6–9 which function possibly as a hinge that allows the
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CSN2 to bend upwards towards the CRL2. The plasticity of these
N-terminal helices presumably permits the binding of deneddy-
lated and alternative Cullin isoforms. HDX-MS further indicates
that RBX1 and CSN4 form an interface, which is more prominent
in the absence of NEDD8, as shown through stabilisation of the
two interfaces (Supplementary Fig. 21b). Overall, the conforma-
tional variations seen in the CSN2 N-terminal helical modules
(Fig. 2b), the bend of CRL2 (Fig. 2c) and the HDX differences in
CSN4/RBX1 (Supplementary Fig. 21b) may therefore be attri-
butable to the seemingly promiscuous afﬁnity that allows CSN2
to bind to each of the different Cullins regardless of neddylation.
We uncovered structural and dynamical aspects of both the
neddylated and deneddylated CSN–CRL2 complexes. Beginning
our interpretation from valuable studies of the CSN–CRL1~N8
and CSN–CRL4A~N8 systems, we propose several major con-
formational switches of the CSN which must be activated by the
CRL2 substrate to bring about deneddylation. While some of
these steps are conserved ubiquitously among other CSN-CRL
complexes (e.g. CSN2/CSN4 clamping in CSN–CRL1~N8 and
CSN–CRL4A~N8), our study suggests additional steps for the
CRL2-bound CSN complex (Fig. 5). In the ﬁrst activation step,
the CSN and CRL2~N8 associate through major conformational
changes in CSN2 and CSN4, which clamp onto the CRL2 (Fig. 5a,
b). Our data suggest that the conformational change in CSN4
breaks its interface with CSN6 through the CSN6 Ins-2 loop and
with the eventual release of the CSN5/CSN6 heterodimer
(Fig. 5c). Removal of the CSN6 Ins-2 loop has been shown in
CSN–CRL1~N8 to disrupt the CSN4–CSN6 interface, leading to
sustained enzymatic activity of the CSN13. In future studies,
targeted deletion of the CSN6 Ins-2 loop can be performed
alongside differential HDX-MS for the CSN–CRL2 system, to
further probe the differences in active site remodelling of CSN5 as
a result of disrupting the CSN4–CSN6 interface.
The release of CSN5/CSN6 appears consistent with the desta-
bilised knotted helices of CSN6 that our HDX has identiﬁed. It is
plausible that these two helices function as the mechanical hinges
which allow the CSN5/CSN6 to be released from their auto-
inhibited conformations but remain tethered to the rest of the
CSN. Although the resolution presented by CSN5 in our cryo-EM
structures prevents us from making molecular level observations,
our HDX data can provide local detail for the CSN5 active site.
The release of CSN5/CSN6 is accompanied by HDX changes in
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areas surrounding the CSN5 active site, including the CSN5 Ins-2
loop. Up to here, the changes experienced by the CSN can be
brought about in a NEDD8-independent manner. In the next
stage, the presence of NEDD8 acts as a selectivity ﬁlter which
results in remodelling of the CSN5 active site itself (Fig. 5d).
These changes presumably expose the CSN5 JAMM ligands of the
metalloprotease site and allow subsequent deneddylation to occur
(Fig. 5e). Finally, deneddylation ensues with the cleavage of
NEDD8 from CRL2 and the dissociation of the complex (Fig. 5f).
The fact that CSN can then reassociate with its CRL2 reaction
product following dissociation, as shown by our study and
structure of the CSN–CRL2, suggests that the non-neddylated
complex may possess an alternative role to deneddylation. By
associating with non-neddylated CRLs, the CSN sterically blocks
access of both ubiquitination E2 enzymes and substrates to the
CRLs16,20. Further studies will be required to fully understand the
deneddylation-independent roles of the CSN. Interestingly, a
comparison of our non-neddylated CSN–CRL2 with the apo-CSN
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and neddylated CSN–CRL4~N8 and CSN–CRL2~N8 complexes,
highlighted the dramatic differences in the conformation of
CSN6. In the absence of NEDD8, the CSN5/CSN6 are released
much further than any other observed conformation of CSN6.
We hypothesise that this difference may arise from the lack of
steric hinderance usually presented by NEDD8, allowing CSN5/
CSN6 to rotate and meet the Cullin scaffold much closer than in
the neddylated structure.
In our study we have made interpretations of the CSN2 and
CSN4 conformational clamping through comparing our cryo-EM
holocomplexes with crystal structures of the apo-CSN. From
reviewing the conformations of all nine currently available
independent copies of the apo-CSN molecule it is apparent that
CSN2 and CSN4 appear to exist in a range of open conformations
that are quite distinct from the closed conformations that we
observed in CSN–CRL2 complexes (Supplementary Fig. 8), and
the similarly closed conformations observed in CSN complexes
with CRL1~N8 and CRL4A~N819,20. However, each of the apo-
CSN crystal structures is characterised by crystal contacts invol-
ving CSN2 and CSN4 which in principle could have biased their
conformations.
Therefore, we used XL-MS to further monitor the conformation
of CSN4 within the solution structure of apo-CSN and found that
both open and closed conformations of apo-CSN are required to
satisfy a number of unique cross-links (Supplementary Fig. 14).
Since our study used lysine cross-links, our distance measure-
ments do not allow for a high level of scrutiny in our modelling
due to the uncertainty of lysine side chain rotamers in our models.
Nonetheless, given that the violated cross-link distances are well
above 40–50 Å for one model and close to 35 Å for the other
(Supplementary Fig. 14), we can assume that both open and closed
conformations are simultaneously represented within the cross-
link ensemble. Thus it seems likely that crystal formation has
stabilised CSN conformations already present in solution. Hence,
while we cannot completely rule out the possibility that the
crystallographically deﬁned open conformations of apo-CSN are
atypical, it seems likely that the solution structure of the apo-CSN
corresponds to an ensemble containing a range of open structures
including those seen crystallographically as well as some closed or
nearly closed structures. In comparison, CSN2 and CSN4 in the
cryo-EM structures of CSN–CRL2 complexes adopt consistently
closed conformations sandwiching the C-terminal end of CUL2
with rather little apparent conformational variation. It is likely
here that conformational variation is limited by interactions
formed with CUL2. Thus it would appear that the interaction
between CSN and CRL2 involves the transition of CSN from an
ensemble of conformers with substantial variation in the distance
between CSN2 and CSN4 to a bound complex in which CSN2 and
CSN4 clamp onto the C-terminal region of CUL2 which is
characterised by greatly reduced conformational variation.
To further explore the nature of such clamped complexes, we
additionally performed PLIMSTEX experiments which provided
localised afﬁnity values between CSN4 and CUL2 for each
combination of the CSN–CRL2. From a functional perspective,
our PLIMSTEX experiments also determined that the H138A
mutation of CSN5 leads to measurable changes in Kd between
CSN4 and CRL2. It is also important to note that the Kd values
presented are not representative of the global Kd between CSN
and CRL2 complexes but are only local afﬁnities between the
CSN4 and CRL2 subunits. PLIMSTEX experiments require that
the labelling time of the experiment is carefully selected based on
preliminary experiments34. While powerful, a concern is that if
the labelling time is too long, protein interfaces may become over-
deuterated, leading to an underestimated deuterium uptake
decrease and a higher Kd value. Likewise, some interfaces may
appear invisible if the labelling time is not sufﬁciently long to
allow deuteration to occur.
In both neddylated and non-neddylated CSN–CRL2 com-
plexes, we identiﬁed an interface between CSN1 and ELOB. So
far, CSN1 has been shown to interact with Skp2 and Fbw7 in
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CRL1~N816 and DDB1 in CRL4A~N8 holocomplexes20. Muta-
tions of the CSN1–DDB1 interface did not affect binding to the
CSN nor perturb deneddylation activity20. In the absence of
Cullin 1 or RBX1, CRL1 substrate receptors do not associate with
the CSN116. Although no CSN activator role has been assigned to
CSN1-substrate receptor interactions, their presence increases the
interface between CSN and their CRL substrates16 and may sta-
bilise these interactions.
Furthermore, there may be additional roles for the CSN as
suggested by the compositional plasticity seen in our
CSN–CRL2~N8 classes. In our map of the CSN–CRL2~N8, the
Cullin arm was observed to shift downwards away from CSN3 in
maps deﬁcient of the VHL substrate receptor (Supplementary
Fig. 26), consistent with the coupling of VHL binding to a con-
formational change in the rest of the CRL2 portion of the protein.
This type of behaviour may allow the CRL2 to adapt to individual
substrates and substrate receptors which vary in size and geometry
as has been suggested with the CRL4A system20. In addition, it may
reﬂect changes associated with remodelling of the CRL2 by the
dissociation of the VHL and the binding of alternative substrate
receptors. In future work we will seek to determine whether the
CSN can mediate substrate receptor dissociation.
Overall, our study has provided greater detail into the role of
CRL2 and NEDD8 in regulating the activation mechanism of
CSN. We propose that the series of mechanistic responses of
the CSN that lead up to deneddylation, can be triggered even by
the CRL2 reaction product in a NEDD8-independent manner.
The presence of NEDD8 on the activated CRL2 substrate would
then trigger the remodelling within the catalytic site of the
CSN5 subunit during the ﬁnal stage of CSN activation. We
envision that this type of mechanism would have implications
for the entire family of CRL proteins and their regulatory
relationship with the CSN. Our study therefore provides a
template not only for assisting investigations of other CRL-
based systems but also for bringing together data from different
structural biology techniques that otherwise will be reported
independently.
Methods
Preparation and expression of bacmids. WT and catalytically reduced
CSN5H138A bacmids were a kind gift from Radoslav Enchev (The Francis Crick
Institute, London)19. pcDNA3-myc3-CUL2 was a gift from Yue Xiong (Addgene
plasmid #1989235). HA-VHL wt-pBabe-puro was a gift from William Kaelin
(Addgene plasmid #1923436). RBX1, ELOB and ELOC were cloned from cDNA
from the Mammalian Gene Collection purchased from Dharmacon. To improve
protein yield, an N-terminally truncated (1–53) natural isoform of VHL was also
produced for use with MS. Both isoforms of VHL were subcloned into a pET-52b
(+) vector (Novagen) to add an N-terminal Step-Tag II. Genes were assembled into
pACEBac1 using I-CeuI/BstXI restriction sites via the MultiBac system37. RBX1
and CUL2 were assembled into one vector and ELOB, Strep II-VHL(ΔN) and
ELOC into a second vector. Correct assembly was conﬁrmed by sequencing of
entire genes. DH10EmBacY cells were transformed with each assembly and blue/
white selection was performed on L-agar plates containing 50 μg ml−1 kanamycin,
7 μg ml−1 gentamycin, 10 μg ml−1 tetracyclin, 100 μg ml−1 Bluo-Gal (Thermo
Scientiﬁc) and 40 mgml−1 IPTG. DH10MultiBac bacmid DNA was isolated from
single white colonies. Recombinant baculoviruses were generated in Sf9 insect cells
(a clonal isolate from Sf21, Life Technologies #11496015) using standard ampli-
ﬁcation procedures.
Expression and puriﬁcation of recombinant CRL2. High Five Cells (BTI-TN-
5B1-4, from embryonic tissue of the cabbage looper, Trichoplusia ni, Life Tech-
nologies #B85502) were co-infected with bacmids containing RBX1/CUL2 and
ELOB/Strep-II VHL(ΔN)/ELOC and incubated at 27 °C and 130 r.p.m. for 72 h.
Cells were harvested by centrifugation at 250 × g for 10 min at 4 °C before storage
at −80 °C. Freeze-thawed pellets were resuspended in 50 mM Tris pH 7.5, 150 mM
NaCl, 2 mM DTT containing complete EDTA-free protease inhibitor tablets
(Roche) and Benzonase (Sigma-Aldrich). Cells were lysed by sonication and
clariﬁed by centrifugation at 25,000 × g for 1 h (Beckman JA-20 rotor). Supernatant
was bound to a 3 × 5ml StrepTrap HP columns (GE Healthcare) in tandem,
equilibrated with 50 mM Tris pH 7.5, 150 mM NaCl and 2 mM DTT. Protein was
eluted by the addition of 2.5 mM d-desthiobiotin. The eluted peak fractions were
concentrated to 2 ml and loaded onto a Superdex 200 16/600 (GE Healthcare) size
exclusion column equilibrated with 50 mM HEPES pH 7.5, 150 mM NaCl and
1 mM TCEP. All CRL2 and CRL2~N8 samples used throughout were in 50 mM
HEPES pH 7.5, 150 mM NaCl and 1 mM TCEP.
In vitro neddylation of CRL2. APPBP1-Uba3, UbcH12 and Nedd8-His were
purchased from (Enzo Life Sciences). The neddylation reaction was carried out for
10 min at 37 °C with 8 μM CRL2, 350 nM APPBP1-Uba3, 1.8 μM UbcH12 and
50 μM Nedd8 in a reaction buffer (50 mM HEPES pH 7.5 and 150 mM NaCl)
supplemented with 1.25 mM ATP and 10 mM MgCl2. The reaction was quenched
with 15 mM DTT and ice prior to loading onto a 1 ml StrepTrap HP column (GE
Healthcare). CRL2~N8 was eluted with reaction buffer supplemented with 2.5 mM
desthiobiotin and neddylation was conﬁrmed by SDS-PAGE.
Expression and puriﬁcation of recombinant CSN. High Five Cells were co-
infected with the bacmids gifted by Radoslav Enchev (The Francis Crick Institute,
London) and protein was expressed as described for CRL2, with an additional Ni-
afﬁnity step prior to gel ﬁltration to exploit the His6-tag on the CSN5 subunit. For
Strep-afﬁnity chromatography 50 mM HEPES pH 7.5, 200 mM NaCl, 2 mM TCEP
and 4% glycerol buffer was used, with the addition of 2.5 mM d-desthiobiotin for
elution. For Ni-afﬁnity using 2× HisTrap HP columns (GE Healthcare) in tandem,
the same buffer was used, but protein was eluted by a 0–300 mM Imidazole gra-
dient across 45 ml. For size exclusion chromatography using a Superdex 200 16/600
(GE Healthcare), the column was equilibrated with 50 mM HEPES pH 7.5, 150 mM
NaCl, 1 mM TCEP and 2% glycerol. All CSN and CSNWT samples used throughout
were in 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT and 1% glycerol.
Cryo-EM of CSN–CRL2~N8. The CSN–CRL2~N8 complex was formed by incu-
bation between CRL2~N8 (1.1× molar excess) and CSN at room temperature for
90 min. The preparation (~0.5 MDa) was subjected to size exclusion chromato-
graphy using a Superose 6 Increase 3.2/300 column (GE Healthcare), equilibrated
in 15 mM HEPES pH 7.5, 100 mM NaCl, 0.5 mM DTT and 1% glycerol to reduce
the contribution of apo components. Fractions from the leading edge of the peak
were buffer exchanged into 15 mM HEPES pH 7.5 and 100 mM NaCl using PD
SpinTrap G-25 columns (GE Healthcare) before initial assessment by negative stain
EM. Cryo-grids were prepared using a Vitrobot (FEI). A cryo-EM dataset was
collected beamline M02 from Quantifoil grids with an extra carbon layer at the
Electron Bio-Imaging Centre (eBIC—Diamond Light Source, UK) on a Titan Krios
300 kV with Gatan K2 detector (M02), Å pix−1= 1.06. Movies of 25 frames (dose
= 1.85 e Å−2) were motion corrected in RELION38 (2.0) using MOTIONCOR239
(01-30-2017) and subsequent CTF estimation of micrographs was performed using
CTFFIND440 (4.1.5) (Supplementary Fig. 1). Auto-picking selected ~317,000
particles from ~3100 micrographs. Particles were subjected to reference free 2D
classiﬁcation to assess data quality and to remove contaminants selected by auto-
picking. This process reduced the particle number to ~250,000. Following particle
selection through 2D classiﬁcation, particles were divided into 15 3D classes. Three
of these classes (~69,000 particles) were selected for further classiﬁcation and
processing, as described in Supplementary Fig. 2.
Cryo-EM of CSN–CRL2. The CSN–CRL2 complex was formed by incubation
between CRL2 (1.1× molar excess) and CSN at room temperature for 90 min.
Samples were loaded onto a 5–50% glycerol GraFix27 gradient containing 0–0.2%
glutaraldehyde and ultracentrifuged at 86,000 × g for 24 h at 4 °C. Gradients were
manually fractionated and the resultant aliquots assessed by SDS-PAGE to deter-
mine the extent of cross-linking. Fractions were also assessed using negative stain
EM in-house. In order to reduce the glycerol content of samples for cryo-EM,
fractions containing the desired complex (as determined by negative stain EM)
were pooled together and gel ﬁltered into 15 mM HEPES pH 7.5, 100 mM NaCl
and 0.5 mM DTT using a Superose 6 Increase 10/300 GL column (GE Healthcare).
Fractions were again assessed by negative stain before preparing cryo-grids using a
Vitrobot (FEI). A cryo-EM dataset was collected at the Electron Bio-Imaging
Centre (eBIC—Diamond Light Source, UK) on a Titan Krios 300 kV with Gatan
K2 detector (M02), with a sampling of 1.047 Å pix−1. Movies of 85 frames (dose=
1.0 e Å−2) were motion corrected in RELION41 (3.0) using MOTIONCOR239 (01-
30-2017) and subsequent CTF estimation of micrographs was performed using
CTFFIND440 (4.1.5). Auto-picking selected ~309,000 particles from ~6800
micrographs. Particles were subjected to reference free 2D classiﬁcation to assess
data quality and to remove contaminants selected by auto-picking. This process
reduced the particle number to ~208,000. Following particle selection through 2D
classiﬁcation, particles were divided into six 3D classes ﬁrst with alignment, then
subsequently without alignment with a mask around CSN5/CSN6 in order to
perform focused classiﬁcation on this area. The map that showed the greatest
recovery of detail for CSN5/CSN6 (Supplementary Fig. 11) was then subjected to
3D auto reﬁnement and post-processing. Local resolution was estimated using
ResMap42 as part of the RELION wrapper.
Band-shift assays. In order to test the activity of the CSN and CSNWT, 3 μg of
each complex was separately incubated with 3 μg of CRL2~N8 at 37 °C for 0, 15,
30, 45 and 60 s. Deneddylation was quenched through rapid denaturation by the
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addition of NuPAGE lithium dodecyl sulfate sample buffer (Thermo Fisher) and
placing on a heat block, pre-heated to 90 °C. Samples were analysed by SDS-PAGE.
Deneddylation in samples with the CSNWT were conﬁrmed by a band shift the gel
band corresponding to CUL2, by comparison with CRL2~N8 and CRL2 controls.
Homology modelling of the CRL2. Homology modelling of the CRL2 was
necessary due to a combination of missing domain structure for the CUL2
Winged-Helix A (WHA) and VHL subunit in the only crystal structure of CRL2
(PDB 5N4W). Homology modelling was performed through two stages: ﬁrst,
generating a CRL2 structure with a correct WHA domain, and second, generating
the complete CRL2 intact with the VHL-ELOB-ELOC adaptor complex. In the ﬁrst
stage, we performed structural alignment of the CRL2 (5N4W) and CRL1 (1LDJ)
structures in PyMOL (2.0.6). Using MODELLER43 (9.16), a single model of the
CRL2 was generated using the slow molecular reﬁnement option of MODELLER.
The model was manually evaluated for correct fold, including the correct posi-
tioning of residues (such as the CUL2 K689 NEDD8-acceptor site) already present
in the 5N4W crystal structure. In the second stage, we aligned the CRL2 model
with the VHL-ELOB-ELOC-CUL2 fragment (4WQO) to generate a template for
homology modelling. The isoform 3 of VHL (missing residues 1–53) was used for
modelling to maintain consistency with the experimental construct. Again, a single
model of the CRL2 (with VHL/ELOB/ELOC) was generated using the slow
molecular reﬁnement option of MODELLER. The ﬁnal model of the CRL2 shows a
RMSD of 3.6 Å when compared with the initial crystal structure (5N4W) but
includes a complete WHA domain and VHL subunit. The script used can be found
in Supplementary Note 1.
Model ﬁtting of EM maps. All models were ﬁtted using CSN subunits sourced
from the 4D10 crystal structure (chains A–H) and the CRL2 (VHL-ELOB-ELOC)
structure generated and described in the Homology Modelling of the CRL2 section.
We performed map ﬁtting ﬁrst by performing rigid body ﬁtting of the CSN and
CRL2 subunits to each map in Chimera44 (1.13.1rc) then using the MDFF25 (0.5)
feature of NAMD45 for positional reﬁnement. In the rigid body ﬁtting step,
elongated subunits such as CSN2, CSN4 and CUL2 were ﬁrst dissected into smaller
rigid bodies to permit better ﬁtting into their densities. Following map ﬁtting of all
CSN and CRL2 subunits, we then converted the structures into MDFF-compatible
topology ﬁles using the protein structure ﬁle builder function of VMD46 (1.9.3).
MDFF was performed in two steps: an initial energy minimisation step (scaling
factor= 0.3 for 50,000 steps) which coerced each subunit into their map densities,
and a second equilibration run (scaling factor= 10 for 200,000 steps) which
applied molecular dynamics to produce structurally and energetically realistic
structures. Secondary structure, cis-peptide and chirality characteristics of the
initial models were calculated and enforced throughout each step to avoid a loss of
internal structure for each subunit. For each of the CSN–CRL2~N8 and
CSN–CRL2 structures, subunits/domains which lacked clear density were not
included to avoid interference with the ﬁtting of other subunits. These were the
WHB domain (CUL2 residues 656–745) for all maps, NEDD8 in all NEDD8-
including maps, and VHL in the CSN–CRL2 map. The cross-correlation coefﬁcient
which calculates the degree of overlap between the cryo-EM map and a simulated
map of the same resolution from the atomic model, are reported for each model in
Table 1 of the manuscript.
Native mass spectrometry. All spectral data were collected using a SYNAPT G2-
Si (Waters Corp., Manchester, UK) high-deﬁnition mass spectrometer and samples
were ionised using a NanoLockSpray™ dual electrospray inlet source (Waters
Corporation) run with positive polarity in sensitivity mode. Capillaries were pulled
using a Flaming/Brown P-97 micropipette puller (Sutter Instrument) and coated
with Au:Pd (80:20) using a sputter coater (Quorum Q150RS). The following mass
spectrometer settings were used: capillary voltage 1.60–1.75 kV, sampling cone of
75–150 V, source temperature of 20 °C, desolvation temperature 150 °C and col-
lision energy of 25–75 eV. Gas pressures were: source 9.3 × 10−3 mbar, trap 3.3 ×
10−2 mbar, helium cell 3.4 mbar, drift tube 2.6 mbar, transfer 3.1 × 10−2 mbar and
time-of-ﬂight 5.7 × 10−7 mbar.
A 1:1 ratio of CSN:CRL2~N8 and CSNWT:CRL2 at a 5–15 μM concentration
were pre-incubated for 1 h prior to buffer exchange. Pre-incubated protein samples
were buffer exchanged and desalted using Vivaspin 500 (30 kDa MWCO)
centrifugal concentrators (Sartorius) into pH 7.5 150 mM ammonium acetate (four
wash steps). All spectra were analysed using MassLynx (4.1, Waters Corp.).
HDX-MS. HDX-MS experiments were performed on a Synapt G2-Si HDMS
coupled to an Acquity UPLC M-Class system with HDX and automation (Waters
Corporation, Manchester, UK). Data were collected in positive polarity in sensi-
tivity mode and calibrated using sodium iodide. The following mass spectrometer
settings were used: capillary voltage of 3 kV, sampling cone of 100 V, source
temperature of 80 °C and desolvation temperature of 150 °C. Acquisition mass
range was set to 50–2000 Da. Gas pressures were: source 6.6 × 10−3 mbar, trap
2.9 × 10−2 mbar, helium cell 4.5 mbar, drift tube 3.1 mbar, transfer 2.8 × 10−2 mbar
and time-of-ﬂight 8.2 × 10−7 mbar.
Protein samples were prepared at a concentration of 7.5 μM. Isotope labelling
was initiated by diluting 5 μl of each protein sample into 95 μl of buffer L (10 mM
potassium phosphate in D2O pD 6.6). The protein was incubated at various time
points (0.25, 5 and 30 min) and then quenched in ice cold buffer Q (100 mM
potassium phosphate, brought to pH 2.3 with formic acid (FA)) before being
digested online with a Waters Enzymate BEH pepsin column at 20 °C. The same
procedure was used for undeuterated control, with the labelling buffer being
replaced by buffer E (10 mM potassium phosphate in H2O pH 7.0). The peptides
were trapped on a Waters BEH C18 VanGuard pre-column for 3 min at a ﬂow rate
of 200 μl min−1 in buffer A (0.1% FA ~pH 2.5) before being applied to a Waters
BEH C18 analytical column. Peptides were eluted over 7 min with a linear gradient
of buffer B (8–40% gradient of 0.1% FA in acetonitrile) at a ﬂow rate of 40 μl min−1
with a runtime of 11 min. All trapping and chromatography was performed at
0.5 °C to minimise back exchange. MSE data were acquired with a 25–45 eV
transfer collision energy ramp for high-energy acquisition of product ions. Leucine
Enkephalin (LeuEnk-Sigma) was used as a lock mass for mass accuracy correction
and the MS was calibrated with sodium iodide. The online Enzymate pepsin
column was washed with pepsin wash (1.5 M Gu-HCl, 4% MeOH and 0.8% FA)
recommended by the manufacturer and a blank run using the pepsin wash was
performed between each sample to prevent signiﬁcant peptide carry-over from the
pepsin column. Optimised peptide identiﬁcation and peptide coverage for all
samples was performed from undeuterated controls (three–four replicates). All
deuterium time points were performed in triplicate on different samples on distinct
samples.
Sequence identiﬁcation was made from MSE data from the undeuterated
samples using the Waters ProteinLynx Global Server 2.5.1 (PLGS). Processing
parameters of PLGS were set to: lock mass for charge 1 of 556.2771 Da e−1, lock
mass window of 0.4 Da, low energy threshold of 135.0 counts, elevated energy
threshold of 30.0 counts and intensity threshold of 750 counts. Workﬂow
parameters were: peptide and fragment mass tolerance set to automatic, minimum
fragment ion matches per peptide set to 1, minimum fragment ion matches per
protein set to 7, minimum peptide matches per protein set to 3, primary digest
reagent set to non-speciﬁc, number of missed cleavages 0, false discovery rate
of 100%.
The output peptides were ﬁltered using DynamX (3.0) using the following
ﬁltering parameters: minimum intensity of 2500, minimum and maximum peptide
sequence length of 5 and 30, respectively, minimum MS/MS products of 3,
minimum products per amino acid of 0.1, and a minimum peptide score of 5. In
addition, all the spectra were visually examined and only those with high signal to
noise ratios were used for HDX-MS analysis. The amount of relative deuterium
uptake for each peptide was determined using DynamX (3.0) and are not corrected
for back exchange. State (listing the deuterium uptake per-peptide, per-timepoint
and per-experimental state) and difference (listing the difference in deuterium
uptake between identical peptides of two states compared for each timepoint), were
exported from DynamX. These ﬁles were input to Deuteros47 (1.0.8) which format
the differential data into the Woods Plot format. Statistical ﬁltering of peptides is
then performed to identify those which exhibit signiﬁcant uptake differences
between the two states. Deuteros applies a blanket conﬁdence interval (speciﬁcally,
the 98% conﬁdence interval given as 0 ± DU where DU is the Deuterium uptake
threshold in Daltons) across all peptides of each timepoint. Signiﬁcant peptides for
each timepoint are then exported into a formatting script which is used to project
the ﬁltered data onto a 3D model of the protein (Supplementary Figs. 19 and 20).
PLIMSTEX for CSN–CRL2 complexes. In addition to performing traditional time-
resolved HDX-MS experiments, we also performed PLIMSTEX (protein–ligand
interactions by MS, titrations and HDX) measured on combinations of CSN/CSNWT
and CRL2/CRL2~N8 to derive dissociation constants (Kd). We performed PLIM-
STEX for three complexes: (1) CSN–CRL2~N8, (2) CSN–CRL2 and (3)
CSNWT–CRL2 complexes. The ﬁnal concentration of CSN or CSNWT was ﬁxed at
250 nM. CRL2 or CRL2~N8 were titrated at either 1:0, 1:0.1, 1:0.5, 1:1, 1:2 or 1:0,
1:0.1, 1:0.5, 1:1, 1:5 molar ratios of CSN:CRL2 (0–1250 nM). The sample setup for
each of the three complexes consisted of ﬁve undeuterated references of CSN or
CSNWT, three samples of deuterated CSN or CSNWT, followed by three of each of the
above molar ratios of CSN:CRL2. Datasets for CSN–CRL2~N8, CSN–CRL2 or
CSNWT–CRL2 underwent labelling for either 15 sec or 2min depending on which
exposure time yielded better deuterium uptake differences as a function of [CRL2] or
[CRL2~N8]. HDX-MS data acquisition and data analysis using PLGS and DynamX
were performed as above. Kd values for each complex were derived using a MathCAD
worksheet (v14, Parametric Technology Corp., Needham, USA) kindly provided by
Michael Gross (Washington University in St. Louis, USA). Brieﬂy, the deuterium
uptake of each peptide as a function of increasing [CRL2] or [CRL2~N8] were ﬁtted
using a 1:1 binding model, optimising for three parameters: D0 (initial deuterium
uptake in the absence of [CRL2] or [CRL2~N8]), ΔD (maximum decrease in deu-
terium uptake observed) and β (where β is equal to the association constant, Ka, for
1:1 binding). The quality of the ﬁt is calculated as the root mean square of the
residuals between experimental datapoints and the model values. The PLIMSTEX
data ﬁtting process has been documented in much greater detail elsewhere48–50.
Sample preparation for XL-MS. Twenty microlitres of ~20 μM CSN–CRL2~N8,
CSNWT–CRL2 and apo-CSNWT were each incubated with 1–5 mM BS3 cross-
linker for 1 h at 25 °C and 350 r.p.m. in a thermomixer. After cross-linking,
complexes were (i) separated by gel electrophoresis (NuPAGE) followed by in-gel
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digestion (CSNWT–CRL2, CSNWT and CSN–CRL2~N8) or (ii) digested in solution
(CSNWT–CRL2) and generated peptides were pre-fractionated by gel ﬁltration
(CSN–CRL2~N8). Gel electrophoresis was performed using the NuPAGE system
according to manufacturer’s protocols. In-gel digestion was performed as described
before51. Digestion in solution was performed in the presence of RapiGest (Waters)
according to manufacturer’s protocols. For gel ﬁltration, peptides were dissolved in
30% acetonitrile (ACN), 0.1% triﬂuoroacetic acid and separated on a Superdex
Peptide PC 3.2/30 column (GE Healthcare) at a ﬂow rate of 50 µl min−1.
Mass spectrometry for XL-MS. Peptides were dissolved in 2% ACN, 0.1% FA and
separated by nano-ﬂow liquid chromatography (Dionex UltiMate 3000 RSLC,
Thermo Scientiﬁc; mobile phase A: 0.1% (v/v) FA; mobile phase B: 80% (v/v) ACN,
0.08% (v/v) FA). Peptides were loaded onto a trap column (μ-Pre-column, C18,
100 μm I.D., particle size 5 μm; Thermo Scientiﬁc) and separated with a ﬂow rate of
300 nl min−1 on an analytical C18 capillary column (Acclaim PepMap 100, C18,
75 μm I.D., particle size 3 μm, 50 cm; Thermo Scientiﬁc), with a gradient of 4–90%
(v/v) mobile phase B over 66 min. Separated peptides were directly eluted into a Q
Exactive Plus hybrid quadrupole-Orbitrap (CRL2 and CRL2~N8) or an Orbitrap
Fusion Tribrid Mass Spectrometer (CSN–CRL2~N8) (Thermo Scientiﬁc).
Typical mass spectrometric conditions for the Q Exactive Plus were: spray
voltage of 1.6–2.1 kV; capillary temperature of 250 °C; normalised collision energy
of 30%, activation Q of 0.25. The mass spectrometer was operated in data-
dependent mode. Survey full scan MS spectra were acquired in the Orbitrap from
350–1600 or 2000 m/z with a resolution of 70,000 at an automatic gain control
(AGC) target of 3 × 106. The top 20 most intense ions were selected for Higher
Energy Collisional Dissociation (HCD) MS/MS fragmentation in the Orbitrap
(isolation window, 1.5 or 1.6 m/z). MS/MS spectra were acquired at a resolution of
17,500 at an AGC target of 1 × 105 or 5 × 104. Previously selected ions within
previous 30 s were dynamically excluded for 30 s. Only ions with charge states 2–7
+ were selected. Singly charged ions as well as ions with unrecognised charge state
were excluded. Internal calibration of the Orbitrap was performed using the lock
mass option (lock mass: m/z 445.120025)52.
Typical mass spectrometric conditions for the Orbitrap Fusion were: spray
voltage of 2.5 kV; capillary temperature of 275 °C; collision energy of 30% and
activation Q of 0.25. The mass spectrometer was operated in data-dependent mode.
Survey full scan MS spectra were acquired in the Orbitrap from 500–1700 or 2000
m/z with a resolution of 120,000 at an AGC target of 5 × 104. The most intense ions
were selected for HCD MS/MS fragmentation in the Orbitrap (3 s cycle time with a
maximum injection time of 128 ms; isolation window, 1.6 m/z). MS/MS spectra
were acquired at a resolution of 30,000 at an AGC target of 5 × 104. Previously
selected ions within previous 30 s were dynamically excluded for 20 s. Only ions
with charge states 3–8+ were selected. Singly and doubly charged ions as well as
ions with unrecognised charge state were excluded. Internal calibration of the
Orbitrap was performed using the lock mass option (lock mass: m/z 445.120025)52.
Data analysis for XL-MS. Raw ﬁles were converted into Mascot generic format
(mgf) ﬁles using pXtract (http://pﬁnd.ict.ac.cn/software/pXtract/index.html). Mgf’s
were searched against a reduced database containing CSN and CRL2 proteins using
pLink1.0 search engine. Search parameters were: instrument spectra, HCD;
enzyme, trypsin; max missed cleavage sites, 3; variable modiﬁcations, oxidation
(methionine) and carbamidomethylation (cysteine); cross-linker, BS3; min peptide
length, 4; max peptide length, 100; min peptide mass, 400 Da; max peptide mass,
10,000 Da; false discovery rate, 1%. Potential cross-linked dipeptides were evaluated
by their spectral quality. Circular network plots were generated using the XVis53
webserver (https://xvis.genzentrum.lmu.de/login.php).
XL-MS guided placement of the WHB, NEDD8 and VHL subunits. Cross-links
determined from XL-MS for the CSN–CRL2~N8 and CSN–CRL2 complexes were
used to clarify the position of the WHB, NEDD8 and VHL subunits which lacked
clear density in our cryo-EM maps. We performed XL-guided placement using the
Integrative Modelling Platform (IMP)54 (2.6), using as input, the map-ﬁtted
models of the CSN–CRL2~N8 and CSN–CRL2. The CSN–CRL2~N8 model post-
map ﬁtting, included all subunits except the WHB and NEDD8. Similarly, the
CSN–CRL2 model included all subunits except the WHB and VHL. Separately, the
subunits of each complex were initialised as coarse-grained bead models, repre-
senting each residue as a single bead. The WHB domain (CUL2 residues 656–745)
and VHL was sourced from the homology model of the CRL2 (detailed in the
section Homology Modelling of the CRL2). NEDD8 was sourced from the crystal
structure of neddylated CRL5 (3DQV). WHB, NEDD8 and VHL were set as mobile
rigid bodies, while all other subunits were kept stationary.
Our modelling procedure utilised two types of cross-links. The ﬁrst type are
pseudo-cross-links that maintain the correct topology of the complex: a single
pseudo-cross-link between CUL2T655 to WHBT656 of 5 Å to mimic a covalent
bond, and connections between VHL-ELOB, VHL-ELOC and VHL-CUL2 to
maintain integrity of the VHL-ELOB-ELOC adaptor complex and its interface with
CUL2. A single pseudo-cross-link of 10 Å was used to mimic the isopeptide bond
of WHBK689~N8G76 (7.5 Å lysine side chain+ ~3 Å glycine C-terminus). The
second type are cross-links determined experimentally between WHB, NEDD8 and
VHL with its surrounding subunits (Supplementary Data 2, 3) which utilised a
distance threshold of 35 Å (two lysine side chains at 15 Å, BS3 linker length at 10 Å,
plus 10 Å for ﬂexibility). IMP was parametrised to perform 1000 iterations, with
each iteration randomly moving WHB, NEDD8 and VHL relative to the stationary
CSN and CRL subunits. IMP parameters used were num_mc_steps= 10,
rb_max_trans= 2, rb_max_rot= 0.1, bead_max_trans= 0.5 and excluded volume
restraint resolution= 20. The single best model was evaluated by projecting all
cross-links for the complex onto the structure and conﬁrming that all distances
were below the 35 Å distance threshold. A table of cross-links can be found in
Supplementary Data 2 for the CSN–CRL2~N8 and Supplementary Data 3
CSNWT–CRL2. The script used can be found in Supplementary Note 2.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The cryo-EM density maps described here have been deposited in the Electron
Microscopy Data Bank (EMDB) under EMD-4739, EMD-4744, EMD-4742, EMD-4736
and EMD-4741. All of the model coordinate sets ﬁtted to the cryo-EM maps have been
deposited in the Protein Data Bank (PDB) under 6R7F, 6R7N, 6R7I, 6R6H and 6R7H. All
XL-MS, HDX-MS and native MS data were deposited to the ProteomeXchange
repository under the accession codes PXD013001 and PXD013018. A list of data
collected for each technique and complex is available in the Supplementary Data 1. The
source data for Figs. 3c, 4c, d and Supplementary Figs. 2, 3, 6, 9a, c, 10, 11d, 13a, c, 14c,
18, 19, 20, 22b, 23b and 25 are detailed in the Source Data ﬁle. All other data are available
from the corresponding authors on reasonable request.
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